- Exchange: BSE India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Saamya Biotech India Ltd
+ Add to WatchlistSBIL:IN
1.68 INR 0.08 5.00%As of 05:07:51 ET on 05/21/2013.
Snapshot for Saamya Biotech India Ltd (SBIL)
| Open: | 1.68 | Day's Range: | 1.68 - 1.68 | Volume: | 25 |
|---|---|---|---|---|---|
| Previous Close: | 1.60 | 52wk Range: | 1.15 - 3.83 | 1-Yr Rtn: | -43.81% |
Key Statistics for SBIL
| Current P/E Ratio (ttm) | 16.8000 |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SENSEX | 1.0398 |
| Earnings Per Share (ttm) | 0.1000 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M INR) | 41.80 |
| Shares Outstanding (M) | 24.88 |
| 30 Day Average Volume | 668 |
| Price/Book (mrq) | 0.1246 |
| Price/Sale (ttm) | 0.1795 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/21/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SBIL
No data available
Company Profile & Key Executives for SBIL
Saamya Biotech India Ltd. manufactures biopharmaceutical ingredients. The Company produces daunomycin and ophthalmic and cosmetic grade hyaluronic acid.
| Y Sonia ReddyChairman/Joint Managing Dir | Y Manivardhan ReddyManaging Director |
| M Bhavani ShankarCompliance Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
SBIL News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page